Michael Schmidt

Stock Analyst at Guggenheim

(4.92)
# 50
Out of 5,042 analysts
120
Total ratings
72.63%
Success rate
34.38%
Average return

Stocks Rated by Michael Schmidt

Genmab
Sep 23, 2025
Upgrades: Buy
Price Target: $43
Current: $29.89
Upside: +43.86%
Incyte
Sep 19, 2025
Reiterates: Neutral
Price Target: n/a
Current: $91.28
Upside: -
Immunome
Aug 25, 2025
Reiterates: Buy
Price Target: $25
Current: $15.69
Upside: +59.34%
Mersana Therapeutics
Aug 14, 2025
Maintains: Buy
Price Target: $125$30
Current: $9.78
Upside: +206.75%
ADC Therapeutics
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $4.09
Upside: +144.50%
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $13.10
Upside: +37.40%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10$12
Current: $3.97
Upside: +202.27%
BeOne Medicines AG
Aug 7, 2025
Maintains: Buy
Price Target: $350$365
Current: $310.81
Upside: +17.44%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16$15
Current: $9.21
Upside: +62.87%
Tango Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $8$10
Current: $7.50
Upside: +33.42%
Reiterates: Buy
Price Target: $17
Current: $15.13
Upside: +12.36%
Reiterates: Buy
Price Target: $80
Current: $54.48
Upside: +46.84%
Reiterates: Buy
Price Target: $45
Current: $18.59
Upside: +142.07%
Maintains: Buy
Price Target: $40$15
Current: $18.97
Upside: -20.93%
Reiterates: Buy
Price Target: $52
Current: $58.56
Upside: -11.20%
Maintains: Buy
Price Target: $30$10
Current: $6.86
Upside: +45.77%
Reiterates: Buy
Price Target: $32
Current: $13.53
Upside: +136.51%
Maintains: Buy
Price Target: $12$8
Current: $19.20
Upside: -58.33%
Reiterates: Buy
Price Target: $109
Current: $94.88
Upside: +14.88%
Maintains: Buy
Price Target: $3$1.75
Current: $0.06
Upside: +2,604.79%
Maintains: Buy
Price Target: $13$14
Current: $7.95
Upside: +76.10%
Reiterates: Neutral
Price Target: n/a
Current: $31.86
Upside: -
Reiterates: Buy
Price Target: $42
Current: $38.72
Upside: +8.47%
Reiterates: Buy
Price Target: n/a
Current: $0.58
Upside: -
Reiterates: Buy
Price Target: $20
Current: $5.10
Upside: +292.16%
Maintains: Buy
Price Target: $12$8
Current: $1.71
Upside: +367.84%
Downgrades: Neutral
Price Target: n/a
Current: $33.18
Upside: -
Upgrades: Buy
Price Target: $7
Current: $0.89
Upside: +686.52%
Downgrades: Neutral
Price Target: n/a
Current: $6.00
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $6.04
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Maintains: Buy
Price Target: $40$34
Current: $13.21
Upside: +157.48%
Initiates: Buy
Price Target: $25
Current: $2.38
Upside: +950.42%
Initiates: Buy
Price Target: $30
Current: $11.14
Upside: +169.30%
Initiates: Buy
Price Target: $26
Current: $5.76
Upside: +351.39%
Downgrades: Neutral
Price Target: n/a
Current: $3.48
Upside: -
Upgrades: Outperform
Price Target: $80
Current: $43.33
Upside: +84.63%
Initiates: Outperform
Price Target: n/a
Current: $8.95
Upside: -
Maintains: Market Perform
Price Target: $4$5.5
Current: $4.36
Upside: +26.15%